Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Jacob E,Berchuck ^[1] ; Daniel,Boiarsky ^[2] ; Rebecca,Silver ^[3] ; Rajitha,Sunkara ^[1] ; Heather M,McClure ^[3] ; Harrison K,Tsai ^[4] ; Stephanie,Siegmund ^[4] ; Alok K,Tewari ^[1] ; Jonathan A,Nowak ^[4] ; Neal I,Lindeman ^[4] ; Huma Q,Rana ^[1] ; Atish D,Choudhury ^[1] ; Mark M,Pomerantz ^[1] ; Matthew L,Freedman ^[3] ; Eliezer M,Van Allen ^[1] ; Mary-Ellen,Taplin ^[1]

作者单位： Dana-Farber Cancer Institute, Boston, MA.;Brigham and Women's Hospital, Boston, MA. ^[1] Tufts Medical Center, Boston, MA. ^[2] Dana-Farber Cancer Institute, Boston, MA. ^[3] Brigham and Women's Hospital, Boston, MA. ^[4]

主题词生殖细胞(Germ Cells);生殖细胞系突变(Germ-Line Mutation);人类(Humans);男(雄)性(Male);前瞻性研究(Prospective Studies);前列腺肿瘤(Prostatic Neoplasms);序列分析(Sequence Analysis)

DOI 10.1200/PO.22.00329

PMID 36103646

发布时间 2024-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2022年6卷

e2200329页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

检索历史清除